BioSpace News Archive

FDA

COVID-19 Update: Pfizer Requests Broad Booster Authorization, Long COVID Questioned

Pfizer and BioNTech requested the FDA authorize booster shots for their COVID-19 vaccine for all adults 18 years and older, presenting data not available in September.

November 10, 2021
·
3 min read
·
Mark Terry
Drug Development

Biogen Investigates Death of 75-Year-Old on Aduhelm

The company is investigating the death of a 75-year-old woman who died of ARIA while receiving Aduhelm.

November 10, 2021
·
4 min read
·
Mark Terry
Global Roundup: Zai Lab Secures Potential Psychiatric Drug For Asian Market

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

November 10, 2021
·
6 min read
·
Alex Keown
Policy

Weighing the Risks and Benefits of the COVID-19 Vaccine for Kids

Between January 4, 2020 and October 30, 2021, COVID-19 accounted for 576 deaths among children 17 and younger, compared to 189 from influenza, according to the CDC.

November 10, 2021
·
6 min read
·
Gail Dutton
Business

Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Otonomy, Inc. The company will host a conference call and webcast today at 4:30 p.m. ET to discuss recent highlights and financial results.

November 10, 2021
·
13 min read
Business

Palatin to Report First Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on November 15, 2021

Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter, fiscal year 2022 operating results on Monday, November 15, 2021 before the open of the U.S. financial markets.

November 10, 2021
·
1 min read
Business

SQZ Biotechnologies Reports Third Quarter 2021 Financial Results and Recent Portfolio Updates

SQZ Biotechnologies today reported third quarter 2021 financial results and recent portfolio updates.

November 10, 2021
·
8 min read
Lone Star Bio

Lumos Pharma to Participate in Upcoming Investor Conferences - Nov 10, 2021

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will participate in the following upcoming investor conferences.

November 10, 2021
·
2 min read
Pharm Country

Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World’s Most Vulnerable People through Novel Humanitarian Buffer

Johnson & Johnson has entered into an agreement with the U.S. Government and Gavi, the Vaccine Alliance, to enable access to its single-shot COVID-19 vaccine through a novel mechanism – the COVAX Humanitarian Buffer – that will serve to protect the world’s most vulnerable people.

November 10, 2021
·
7 min read
Business

Optinose Announces Reporting Date for Third Quarter 2021 Financial Results

Conference Call and Webcast to be held November 16, 2021 at 8:30 a.m. Eastern Time

November 10, 2021
·
1 min read